Interferon beta-1b in the treatment of patients with active relapsing-remitting or secondary progressive multiple sclerosis:: results of a Markov disease model for Sweden and the UK

被引：0
|
作者：
Kobelt, G
Jönsson, L
Fredrikson, S
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Stockholm Hlth Econ Consulting, Stockholm, Sweden
[3] Huddinge Univ Hosp, Stockholm, Sweden
来源：
JOURNAL OF NEUROLOGY | 2004年 / 251卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [21] Interferon beta-1a in relapsing-remitting multiple sclerosis
    Blumhardt, L
    HOSPITAL MEDICINE, 1999, 60 (03): : 192 - 195
  • [22] Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b
    Borràs, C
    Río, J
    Porcel, J
    Barrios, M
    Tintoré, M
    Montalban, X
    NEUROLOGY, 1999, 52 (08) : 1636 - 1639
  • [23] COST-UTILITY ANA LYSIS OF INTRAMUSCULAR INTERFERON BETA-1B VERSUS SUBCUTANEOUS INTERFERON BETA-1B AND BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN COLOMBIA
    Ordonez, J.
    Delgado, A.
    VALUE IN HEALTH, 2016, 19 (03) : A63 - A63
  • [24] Interferon-beta treatment and active replication of the JC virus in relapsing-remitting multiple sclerosis patients
    Alvarez-Lafuente, R.
    Garcia-Montojo, M.
    De Las Heras, V.
    Bartolome, M.
    Arroyo, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (02) : 233 - 236
  • [25] Interferon-β-1b -: A review of its use in relapsing-remitting and secondary progressive multiple sclerosis
    McCormack, PL
    Scott, LJ
    CNS DRUGS, 2004, 18 (08) : 521 - 546
  • [26] Predictors of Conversion to Secondary Progressive Multiple Sclerosis in Patients with Relapsing-Remitting Multiple Sclerosis
    Kappos, L.
    Meier, D. P.
    Tomic, T.
    Haring, D.
    Bakshi, R.
    Meinert, R.
    Giovannoni, G.
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 447 - 447
  • [27] Azathioprine and interferon β-1b treatment in relapsing-remitting multiple sclerosis
    Milanese, C
    La Mantia, L
    Salmaggi, A
    Caputo, D
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (03): : 413 - 414
  • [28] Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
    Cocco, Eleonora
    Marrosu, Maria Giovanna
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 759 - 766
  • [29] Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis
    Conte, A.
    Lenzi, D.
    Frasca, V.
    Gilio, F.
    Giacomelli, E.
    Gabriele, M.
    Bettolo, C. Marini
    Iacovelli, E.
    Pantano, P.
    Pozzilli, C.
    Inghilleri, M.
    JOURNAL OF NEUROLOGY, 2009, 256 (06) : 933 - 938
  • [30] Predictors of Conversion to Secondary Progressive Multiple Sclerosis in Patients With Relapsing-Remitting Multiple Sclerosis
    Tomic, Davorka
    Kappos, Ludwig
    Meier, Daniela Piani
    Haring, Dieter
    Meinert, Rolf
    Giovannoni, Gavin
    Chitnis, Tanuja
    NEUROLOGY, 2018, 90
12345